170 related articles for article (PubMed ID: 23348836)
1. Predictors of squamous cell carcinoma in high-risk patients in the VATTC trial.
Xiong MY; Rizzo AE; Cohen TS; Dyer RK; Korgavkar K; Bingham SF; Weinstock MA;
J Invest Dermatol; 2013 Jun; 133(6):1521-32. PubMed ID: 23348836
[TBL] [Abstract][Full Text] [Related]
2. Predictors of basal cell carcinoma in high-risk patients in the VATTC (VA Topical Tretinoin Chemoprevention) trial.
Dyer RK; Weinstock MA; Cohen TS; Rizzo AE; Bingham SF;
J Invest Dermatol; 2012 Nov; 132(11):2544-51. PubMed ID: 22810303
[TBL] [Abstract][Full Text] [Related]
3. Tretinoin and the prevention of keratinocyte carcinoma (Basal and squamous cell carcinoma of the skin): a veterans affairs randomized chemoprevention trial.
Weinstock MA; Bingham SF; Digiovanna JJ; Rizzo AE; Marcolivio K; Hall R; Eilers D; Naylor M; Kirsner R; Kalivas J; Cole G; Vertrees JE;
J Invest Dermatol; 2012 Jun; 132(6):1583-90. PubMed ID: 22318383
[TBL] [Abstract][Full Text] [Related]
4. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.
Christian JB; Lapane KL; Hume AL; Eaton CB; Weinstock MA;
J Natl Cancer Inst; 2008 Sep; 100(17):1223-32. PubMed ID: 18728281
[TBL] [Abstract][Full Text] [Related]
5. Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial.
Criscione VD; Weinstock MA; Naylor MF; Luque C; Eide MJ; Bingham SF;
Cancer; 2009 Jun; 115(11):2523-30. PubMed ID: 19382202
[TBL] [Abstract][Full Text] [Related]
6. Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use.
van der Pols JC; Williams GM; Pandeya N; Logan V; Green AC
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2546-8. PubMed ID: 17132769
[TBL] [Abstract][Full Text] [Related]
7. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer.
Karagas MR; Greenberg ER; Mott LA; Baron JA; Ernster VL
Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):157-61. PubMed ID: 9488591
[TBL] [Abstract][Full Text] [Related]
8. Association between statin use and risk for keratinocyte carcinoma in the veterans affairs topical tretinoin chemoprevention trial.
Dore DD; Lapane KL; Trivedi AN; Mor V; Weinstock MA
Ann Intern Med; 2009 Jan; 150(1):9-18. PubMed ID: 19124815
[TBL] [Abstract][Full Text] [Related]
9. Oral prednisone use and risk of keratinocyte carcinoma in non-transplant population. The VATTC trial.
Baibergenova AT; Weinstock MA;
J Eur Acad Dermatol Venereol; 2012 Sep; 26(9):1109-15. PubMed ID: 21923839
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous squamous cell carcinoma in human immunodeficiency virus-infected patients. A study of epidemiologic risk factors, human papillomavirus, and p53 expression.
Maurer TA; Christian KV; Kerschmann RL; Berzin B; Palefsky JM; Payne D; Tyring SK; Berger TG
Arch Dermatol; 1997 May; 133(5):577-83. PubMed ID: 9158410
[TBL] [Abstract][Full Text] [Related]
11. Chemoprevention of Basal and Squamous Cell Carcinoma With a Single Course of Fluorouracil, 5%, Cream: A Randomized Clinical Trial.
Weinstock MA; Thwin SS; Siegel JA; Marcolivio K; Means AD; Leader NF; Shaw FM; Hogan D; Eilers D; Swetter SM; Chen SC; Jacob SE; Warshaw EM; Stricklin GP; Dellavalle RP; Sidhu-Malik N; Konnikov N; Werth VP; Keri JE; Robinson-Bostom L; Ringer RJ; Lew RA; Ferguson R; DiGiovanna JJ; Huang GD;
JAMA Dermatol; 2018 Feb; 154(2):167-174. PubMed ID: 29299592
[TBL] [Abstract][Full Text] [Related]
12. Topical tretinoin therapy and all-cause mortality.
Weinstock MA; Bingham SF; Lew RA; Hall R; Eilers D; Kirsner R; Naylor M; Kalivas J; Cole G; Marcolivio K; Collins J; Digiovanna JJ; Vertrees JE;
Arch Dermatol; 2009 Jan; 145(1):18-24. PubMed ID: 19153339
[TBL] [Abstract][Full Text] [Related]
13. Prospective quality of life impact of keratinocyte carcinomas: observations from the Veterans Affairs Topical Tretinoin Chemoprevention Trial.
Lee KC; Weinstock MA;
J Am Acad Dermatol; 2010 Dec; 63(6):1107-9. PubMed ID: 21093671
[No Abstract] [Full Text] [Related]
14. Evaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses, Squamous Cell Carcinoma, and Basal Cell Carcinoma: A Systematic Review.
Schauder DM; Kim J; Nijhawan RI
JAMA Dermatol; 2020 Oct; 156(10):1117-1124. PubMed ID: 32639538
[TBL] [Abstract][Full Text] [Related]
15. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial.
Green A; Williams G; Neale R; Hart V; Leslie D; Parsons P; Marks GC; Gaffney P; Battistutta D; Frost C; Lang C; Russell A
Lancet; 1999 Aug; 354(9180):723-9. PubMed ID: 10475183
[TBL] [Abstract][Full Text] [Related]
16. Quality of life in the actinic neoplasia syndrome: The VA Topical Tretinoin Chemoprevention (VATTC) Trial.
Weinstock MA; Lee KC; Chren MM; Marcolivio K;
J Am Acad Dermatol; 2009 Aug; 61(2):207-15. PubMed ID: 19398145
[TBL] [Abstract][Full Text] [Related]
17. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study.
Ulrich C; Jürgensen JS; Degen A; Hackethal M; Ulrich M; Patel MJ; Eberle J; Terhorst D; Sterry W; Stockfleth E
Br J Dermatol; 2009 Nov; 161 Suppl 3():78-84. PubMed ID: 19775361
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of incident squamous cell carcinoma of the skin in the nurses' health study.
Grodstein F; Speizer FE; Hunter DJ
J Natl Cancer Inst; 1995 Jul; 87(14):1061-6. PubMed ID: 7616597
[TBL] [Abstract][Full Text] [Related]
19. Fluorouracil and other predictors of morpheaform basal cell carcinoma among high-risk patients: the Veterans Affairs Topical Tretinoin Chemoprevention Trial.
Xiong MY; Korgavkar K; Digiovanna JJ; Weinstock MA;
JAMA Dermatol; 2014 Mar; 150(3):332-4. PubMed ID: 24258386
[No Abstract] [Full Text] [Related]
20. Association of Human Papillomavirus Vaccine With the Development of Keratinocyte Carcinomas.
Nichols AJ; Allen AH; Shareef S; Badiavas EV; Kirsner RS; Ioannides T
JAMA Dermatol; 2017 Jun; 153(6):571-574. PubMed ID: 28196178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
